Clinical trial

The Immune Effects of Fermented Wheat Germ Nutritional Supplementation in Patients With Advanced Solid Tumor Cancers Being Treated With Standard of Care Checkpoint Inhibitors

NCT05967533

StatusSUSPENDED

Study typeINTERVENTIONAL

Start date2023-06-02

PhasePHASE1

Study timeline

Study start (actual)2023-06-02Date precision: day

Registry last updated2026-07-01

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Advanced Colorectal Carcinomaunresolved

Advanced Lung Non-Small Cell Carcinomaunresolved

Advanced Malignant Solid Neoplasmunresolved

Advanced Melanomaunresolved

Advanced Renal Cell Carcinomaunresolved

Advanced Triple-Negative Breast Carcinomaunresolved

Anatomic Stage III Breast Cancer AJCC v8unresolved

Anatomic Stage IV Breast Cancer (AJCC) v8unresolved

Clinical Stage III Cutaneous Melanoma AJCC v8unresolved

Clinical Stage IV Cutaneous Melanoma AJCC v8unresolved

Stage III Colorectal Cancer AJCC v8unresolved

Stage III Lung Cancer AJCC v8unresolved

Stage III Renal Cell Cancer AJCC v8unresolved

Stage IV Colorectal Cancer AJCC v8unresolved

Stage IV Lung Cancer AJCC v8unresolved

Stage IV Renal Cell Cancer AJCC v8unresolved

Interventions

Fermented Wheat Germ ExtractDRUG

Sponsors & collaborators

University of California, Davislead sponsor

National Cancer Institute (NCI)collaborator

Mapped research locations

SacramentoCalifornia, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05967533 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.